DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM PAR
Total 13F shares
8,958,103
Share change
-697,055
Total reported value
$2,343,000
Price per share
$0.25
Number of holders
17
Value change
-$86,488
Number of buys
5
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q1 2022

As of 31 Mar 2022, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,958,103 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, TWO SIGMA ADVISERS, LP, Yu Fan, LPL Financial LLC, and ADVISOR GROUP HOLDINGS, INC.. This page lists 17 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.